echemi logo
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Three drugs big price reduction, this drug dropped 1000 yuan!

    Three drugs big price reduction, this drug dropped 1000 yuan!

    • Last Update: 2020-06-16
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit
    On June 1, Liaoning Province Drug and Medical Supplies Centralized Procurement Network issued the "Notice on the implementation of the active price reduction results of 3 drugs, such as dothirave sodium tablets", requiring all medical and health institutions in the province to implement the new online purchase price from 0:00 on June 3.
    Notice shows that recently, Liaoning Province medical institutions medicine and medical supplies centralized procurement of the leading group office received Beijing Branch Park Xinhai Pharmaceutical Management Co., Ltd., Zhengda Tianqing Pharmaceutical Group Co., Ltd., Hangzhou East China Pharmaceutical Co., Ltdand other 3 pharmaceutical companies produced 3 drugs dotrilaved sodium tablets, injection with aphasiads, injection of dattomycin in Liaoning Province to actively reduce the price of the applicationAfter the study, it was agreed to adjust the purchase price sourcing of the three drug networks produced by the three pharmaceutical manufacturers.
    From the three drug network procurement price adjustment situation, the decline of dotrilaved sodium tablets is huge, from 1980 yuan to 980 yuan, hanging net purchase price fell a full 1000 yuanInjection of adatinine, injection dattomycin decreased by 126 yuan, 331 yuan, respectively.
    It is understood that Dothrave sodium was developed by GlaxoSmithKline and ViiV HealthcareIt was approved by the FDA on April 8, 2019 and listed by the European Drug Administration (EMA) on April 26, 2019, and sold in the United States by ViiV Healthcare for the treatment of AIDS ®.
    Data show that AIDS (HIV) is caused by human immunodeficiency virus (HIV) infection, easy to make the human body lose immune functionIf AIDS patients are not treated, the average survival time will be greatly reducedData show that in the first half of 2018, the number of AIDS cases in China was 27,243, and the number of AIDS deaths in China increased rapidlyIn the first half of 2018, the number of AIDS deaths in China was 7,524In general, China's AIDS epidemic situation is still very serious, HIV drug market potential is huge.
    The current price of dothlaveds in Liaoning Province is 1980 yuan, which is a big burden for patients who need to take them, and with the drug's big price reduction, it is conducive to further reducing the burden of drug use.
    The author learned that, in addition to Liaoning Province, according to the Gansu Provincial Public Resources Trading Bureau on May 15, 2020 published "on the publication of some drug platform adjustment, information changes and price adjustment notice" shows that the larger price reduction in this batch is also produced by GSK "doterlave sodium tablets" (50 mg (to do-tlaved), 30 tablets), from the original bid price of 1980 yuan down to 980 yuan.
    In fact, from the current domestic drug price reduction trend, from the national collection to local collection, as well as health care negotiations, whether the original research imported drugs or local drugs are increasingly the price reduction, this price reduction trend is spreading.
    Industry analysts believe that for highly competitive mature products, some of the original research drugs to abandon the price war in favor of brand marketing, for limited competition in mature products, price reduction to defend the market is a wise choice At the same time that the original research drug has joined the tide of price reduction, with the intensification of market competition, domestic enterprises are more proactive in adjusting the price of their products On the whole, the trend of drug price reduction is irreversible, and the variety of products that reduce prices will become more and more abundant, which is undoubtedly great news for domestic patients.
    This article is an English version of an article which is originally in the Chinese language on and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to with relevant evidence.